Pay in 4 interest-free payments of $5.88 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The typical patient has a soft-tissue injury that stalled: they completed physical therapy, have no surgical indication, but are still symptomatic at 8 to 12 weeks
Two separate human clinical trials have investigated this compound: Ulcerative Colitis Trial Clinical investigation of this compound in patients with ulcerative colitis examined the compounds GI-protective properties properties that are consistent with its gastric origin and documented activity on intestinal permeability barriers in animal models
Shannon offers the summary below: The preclinical science is genuinely exciting and promising for regenerative medicine
It is not a clinical recommendation
BPC-157, also known as Body Protection Compound 157, is a synthetic pentadecapeptide studied in laboratory models involving tissue repair signaling, gastrointestinal integrity, inflammatory modulation, and angiogenesis-related biological pathways
Peters, S
US$ 24.36
US$ 24.16
US$ 27.14
US$ 25.60
US$ 29.18
US$ 25.60
US$ 22.77
US$ 24.31
